Translational aspects of the immunology of clostridioides difficile infection: Implications for pediatric populations

Larry K. Kociolek*, Joseph P. Zackular, Tor Savidge

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Clostridioides difficile has become the most common healthcare-associated pathogen in the United States, leading the US Centers for Disease Control and Prevention (CDC) to classify C. difficile as an "urgent"public health threat that requires "urgent and aggressive action."This call to action has led to new discoveries that have advanced our understanding of Clostridioides difficile infection (CDI) immunology and clinical development of immunologic-based therapies for CDI prevention. However, CDI immunology research has been limited in pediatric populations, and several unanswered questions remain regarding the function of host immune response in pediatric CDI pathogenesis and the potential role of immunologic-based therapies in children. This review summarizes the innate and adaptive immune responses previously characterized in animals and humans and provides a current update on clinical development of immunologic-based therapies for CDI prevention in adults and children. These data inform the future research needs for children.

Original languageEnglish (US)
Pages (from-to)S8-S15
JournalJournal of the Pediatric Infectious Diseases Society
Volume10
DOIs
StatePublished - Nov 1 2021

Keywords

  • Antibody
  • C. difficile
  • Immunity
  • Pediatric
  • Vaccine

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Translational aspects of the immunology of clostridioides difficile infection: Implications for pediatric populations'. Together they form a unique fingerprint.

Cite this